{{cart_num}}
My Cart> Analytical Standards > Analytical Reference > Alkaloid > Berberine HydrochlorideCAS：633-65-8
Purity：HPLC≥98%
Molecular Formula：C20H18ClNO4
Molecular Weight：371.81
Appearance：Light yellow to yellow powder
Storage：Store at RT，2 years.
Qty：
Size：
| CAS | 633-65-8 |
| Name | Berberine Hydrochloride |
| Purity | HPLC≥98% |
| Molecular Formula | C20H18ClNO4 |
| Molecular Weight | 371.81 |
| Appearance | Light yellow to yellow powder |
| Solubility | ≥10mg/mL in Methanol |
| Storage | Store at RT，2 years. |
| EC | EINECS 211-195-9 |
| MDL | MFCD00011939 |
| SMILES | COC1=C(OC)C2=C[N+]3=C(C(C(CC3)=C4)=CC5=C4OCO5)C=C2C=C1.[Cl-] |
| InChI | InChI=1S/C20H18NO4.ClH/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2;/h3-4，7-10H，5-6，11H2，1-2H3;1H/q+1;/p-1 |
| Note | The reserve liquid is recommended to be packaged and frozen to avoid repeated freezing and thawing (-20℃, 1 month); The diluted working liquid is recommended to be used and prepared immediately |
| Unit | Bottle |
| Specification | 20mg |
This product is an analytical standard.
Note：Product information may be optimized and upgraded. Please refer to the actual label information for accuracy.
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Antitumor Activity of Berberine by Activating Autophagy and Apoptosis in CAL-62 and BHT-101 Anaplastic Thyroid Carcinoma Cell Lines
Click to check >>Author：Xiang-Zhe Shi, Sheng Zhao, Yan Wang, Meng-Yao Wang, Su-Wen Su, Yan-Zhao Wu, Chen Xiong
IF：4.8000
Publish_to：Drug Design Development and Therapy
PMID：37397788
